Julie Appleby

Visit kff.org to read Julie's bio.

jappleby@kff.org
@Julie_appleby

‘Do The Math’ When Shopping For A Health Plan This Open Enrollment Season

KFF Health News Original

Because of the complexity of insurance available through healthcare.gov and state exchanges, and the broad variation in how prescription drugs are covered, experts encourage consumers to compare options to figure out which one best fits their needs.

Feds Issue Proposed Rule On Health Information Collected By Workplace Wellness Programs

KFF Health News Original

This proposal allows these workplace wellness programs to set financial incentives for participation as high as 30 percent of the cost of family coverage. A separate draft rule pegs this amount to the cost of employee-only coverage.

UnitedHealthcare Expands Effort To Rein In Rising Costs Of Cancer Treatment

KFF Health News Original

As part of an effort to pinpoint what’s driving up health expenditures, the insurer is broadening a pilot program to include about 500 more oncologists, bringing the total to 650 physicians in seven states.

Leslie Michelson’s Checklist For Avoiding Diagnostic Errors – The KHN Conversation

KFF Health News Original

Michelson, who runs a Los Angeles-based company that helps patients research their medical options and has written a book about how to avoid bad care, offers advice on how to navigate the health care system.

Pregnancy – A Touchy Subject In Employee Wellness Health Assessments

KFF Health News Original

Pregnancy questions included in many wellness program questionnaires hit a nerve, and advocates are asking the Obama administration to ban these types of queries as part of a pending Equal Employment Opportunity Commission rule.

Battle Over Dementia Drug Swap Has Big Stakes For Drugmakers, Consumers

KFF Health News Original

A court ruling about Actavis’s strategy to switch consumers from its top-selling dementia drug, which will lose patent protection this summer, to a newer, patent-protected drug, may define how far drugmakers can go to protect profits from generic rivals.